{"SLR NAME":"Hydroxychloroquine for treatment of nonsevere COVID?19 patients: Systematic review and meta?analysis of controlled clinical trials","References":[{"title1":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","References":[{"title2":"Coronavirus covid-19 global cases by Johns Hopkins CSSE. https://www.arcgis.com/apps/opsdashboard/index.html#/85320e2ea5424dfaaa75ae62e5c06e61.","References":[]},{"title2":"Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies","References":[{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"surveillance case definition for severe acute respiratory syndrome (SARS) and update on SARS cases:United States and worldwide, December 2003"},{"title3":"World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV):Saudi Arabia. Disease outbreak news. 2017. http://www.who.int/csr/don/17-january-2017-mers-saudi-arabia/en/. Accessed 24 Jan 2017."},{"title3":"World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). Fact sheet. 2017."},{"title3":"Coronaviruses: an overview of their replication and pathogenesis"},{"title3":"Nidovirus transcription: how to make sense...?"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Replicative capacity of MERS coronavirus in livestock cell lines"},{"title3":"Middle East respiratory syndrome coronavirus in bats, Saudi Arabia"},{"title3":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels"},{"title3":"Review of bats and SARS"},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study"},{"title3":"Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi"},{"title3":"Middle East respiratory syndrome"},{"title3":"Middle East respiratory syndrome (MERS)"},{"title3":"SARS: clinical presentation, transmission, pathogenesis and treatment options"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission"},{"title3":"WHO Mers-Cov Research Group. State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans. PLoS Curr. 2013;5."},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers"},{"title3":"Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"King Abdullah International Medical Research Center. MERS-CoV infection treated with a combination of lopinavir /ritonavir and interferon beta-1b (MIRACLE). Bethesda: National Institutes of Health; 2017. https://clinicaltrials.gov/ct2/show/NCT02845843. Accessed 12 July 2017."},{"title3":"Drug repositioning: identifying and developing new uses for existing drugs"},{"title3":"Loperamide"},{"title3":"Pharmacology of antidiarrheal drugs"},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture"},{"title3":"Loperamide therapy for voluminous diarrhea in Ebola virus disease"},{"title3":"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection"},{"title3":"In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine"},{"title3":"Chloroquine: modes of action of an undervalued drug"},{"title3":"Development and in vitro evaluation of chloroquine gels as microbicides against HIV-1 infection"},{"title3":"Chloroquine inhibits dengue virus type 2 replication in Vero cells but not in C6/36 cells"},{"title3":"A systematic screen of FDA-approved drugs for inhibitors of biological threat agents"},{"title3":"In vitro inhibition of human influenza A virus replication by chloroquine"},{"title3":"Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays"},{"title3":"Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy"},{"title3":"Acidotropic amines inhibit proteolytic processing of flavivirus prM protein"},{"title3":"Effects of chloroquine on viral infections: an old drug against today's diseases?"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies"},{"title3":"Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses"},{"title3":"Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR"},{"title3":"Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors"},{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread"},{"title3":"Toxicology of hydroxychloroquine and chloroquine and the pathology of the retinopathy they cause"},{"title3":"Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1"},{"title3":"Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1"},{"title3":"On chikungunya acute infection and chloroquine treatment"},{"title3":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults"},{"title3":"Lack of protection against ebola virus from chloroquine in mice and hamsters"},{"title3":"Effect of artesunate-amodiaquine on mortality related to Ebola virus disease"},{"title3":"World Health Organization. Categorization and prioritization of drugs for consideration for testing or use in patients infected with Ebola. 2015. http://www.who.int/medicines/ebola-treatment/2015_0703TablesofEbolaDrugs.pdf?ua=1. Accessed 13 Oct 2016."},{"title3":"Identification and characterization of mefloquine efficacy against JC virus in vitro"},{"title3":"A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes"},{"title3":"Mefloquine in the treatment of progressive multifocal leukoencephalopathy"},{"title3":"Cyclophilins: a new family of proteins involved in intracellular folding"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"},{"title3":"Cyclosporin A inhibits the replication of diverse coronaviruses"},{"title3":"Emerging picture of host chaperone and cyclophilin roles in RNA virus replication"},{"title3":"The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus"},{"title3":"The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection"},{"title3":"Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy"},{"title3":"Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice"},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Treatment of SARS with human interferons"},{"title3":"Interferon-beta 1a and SARS coronavirus replication"},{"title3":"Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"FDA-approved small-molecule kinase inhibitors"},{"title3":"Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling"},{"title3":"Protein kinases:the major drug targets of the twenty-first century?"},{"title3":"The druggable genome"},{"title3":"Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus"},{"title3":"Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections"},{"title3":"Into the eye of the cytokine storm"},{"title3":"Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion"},{"title3":"Antiviral potential of ERK/MAPK and PI3 K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis"},{"title3":"Paladin Therapeutics. Impavido (Miltefosine) capsules, for oral use prescribing information. Wilmington: Paladin Therapeutics; 2014. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=d6658aeb-7bc1-4eef-ad0d-0a873ddbecf5&amp;type=display. Accessed 13 July 2017."},{"title3":"Investigational drug available directly from CDC for the treatment of infections with free-living amebae"},{"title3":"Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure"},{"title3":"Phenothiazine: the seven lives of pharmacology's first lead structure"},{"title3":"Inhibition of arenavirus multiplication in vitro by phenotiazines"},{"title3":"Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway"},{"title3":"Ebola virus uses clathrin-mediated endocytosis as an entry pathway"},{"title3":"Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes"},{"title3":"Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine"},{"title3":"Chikungunya virus: an update on antiviral development and challenges"},{"title3":"A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity"},{"title3":"Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs"},{"title3":"Selective inhibition of hepatitis C virus infection by hydroxyzine and benztropine"},{"title3":"Inhibition of Ebola and Marburg virus entry by G protein-coupled receptor antagonists"},{"title3":"Risks of non-sedating antihistamines"},{"title3":"A clinical drug library screen identifies astemizole as an antimalarial agent"},{"title3":"Astemizole: an old anti-histamine as a new promising anti-cancer drug"},{"title3":"Small molecule regulators of autophagy identified by an image-based high-throughput screen"},{"title3":"Divergent roles of autophagy in virus infection"},{"title3":"Identification of a candidate therapeutic autophagy-inducing peptide"},{"title3":"Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus"},{"title3":"Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus"},{"title3":"Development of antiviral therapy for severe acute respiratory syndrome"},{"title3":"Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance"},{"title3":"Coronaviruses as DNA wannabes: a new model for the regulation of RNA virus replication fidelity"},{"title3":"Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA"},{"title3":"Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses"},{"title3":"Pharmacokinetics and bioavailability of mycophenolic acid after intravenous administration and oral administration of mycophenolate mofetil to heart transplant recipients"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV Infection in a nonhuman primate model of common marmoset"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha"},{"title3":"Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabine"},{"title3":"Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection"},{"title3":"Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research"},{"title3":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry"},{"title3":"Effects of protease inhibitors on replication of various myxoviruses"},{"title3":"Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry"},{"title3":"Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection"},{"title3":"Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein"},{"title3":"ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease"},{"title3":"A single-arm, proof-of-concept trial of lopimune (lopinavir/ritonavir) as a treatment for HPV-related pre-invasive cervical disease"},{"title3":"Small molecules targeting severe acute respiratory syndrome human coronavirus"},{"title3":"A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs"},{"title3":"Anisomycin, a new antiprotozoa antibiotic"},{"title3":"Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy"},{"title3":"Anisomycin in intestinal amebiasis; study of 30 clinical cases"},{"title3":"Structural determinants responsible for the biological activity of (-)-emetine, (-)-cryptopleurine, and (-)-tylocrebrine: structure-activity relationship among related compounds"},{"title3":"Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1"},{"title3":"Specificity of protein synthesis inhibitors in the inhibition of encephalomyocarditis virus replication"},{"title3":"Rapid identification of inhibitors that interfere with poliovirus replication using a cell-based assay"},{"title3":"Effect of cantharidin, cephalotaxine and homoharringtonine on &quot;in vitro&quot; models of hepatitis B virus (HBV) and bovine viral diarrhoea virus (BVDV) replication"},{"title3":"Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection"},{"title3":"Anti-hepatitis C virus activity of tamoxifen reveals the functional association of estrogen receptor with viral RNA polymerase NS5B"},{"title3":"FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection"},{"title3":"Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection"},{"title3":"Toremifene interacts with and destabilizes the Ebola virus glycoprotein"},{"title3":"Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications"},{"title3":"Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis"},{"title3":"Chemical combinations elucidate pathway interactions and regulation relevant to Hepatitis C replication"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430"},{"title3":"Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity"},{"title3":"Antiviral drugs specific for coronaviruses in preclinical development"},{"title3":"The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus"},{"title3":"Antiviral RNAi therapy: emerging approaches for hitting a moving target"},{"title3":"Inhibition of SARS-associated coronavirus infection and replication by RNA interference"},{"title3":"Development of interfering RNA agents to inhibit SARS-associated coronavirus infection and replication"},{"title3":"Attenuation of SARS coronavirus by a short hairpin RNA expression plasmid targeting RNA-dependent RNA polymerase"},{"title3":"Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells"},{"title3":"Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus"},{"title3":"Silencing SARS-CoV spike protein expression in cultured cells by RNA interference"},{"title3":"Inhibition of SARS-CoV replication by siRNA"},{"title3":"Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S"},{"title3":"Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in rhesus macaque"},{"title3":"A computational approach for predicting role of human microRNAs in MERS-CoV genome"},{"title3":"Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates"},{"title3":"Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial"},{"title3":"Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity"},{"title3":"Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor"},{"title3":"Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein"},{"title3":"Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein"},{"title3":"Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic"},{"title3":"Stability, toxicity, and biological activity of host defense peptide BMAP28 and its inversed and retro-inversed isomers"},{"title3":"Hydrocarbon-stapled peptides: principles, practice, and progress"},{"title3":"A review of palivizumab and emerging therapies for respiratory syncytial virus"},{"title3":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp"},{"title3":"A randomized, controlled trial of ZMapp for Ebola virus fnfection"},{"title3":"A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection"},{"title3":"Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies"},{"title3":"A neutralizing human monoclonal antibody protects African green monkeys from hendra virus challenge"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"Prophylaxis with a Middle East respiratory syndrome coronavirus (MERS-CoV)-specific human monoclonal antibody protects rabbits from MERS-CoV infection"},{"title3":"Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein"},{"title3":"3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012"},{"title3":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection"},{"title3":"Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection"},{"title3":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution"},{"title3":"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies"},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"},{"title3":"Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections"},{"title3":"Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology"},{"title3":"Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo"},{"title3":"Strategies in the design of antiviral drugs"},{"title3":"AIDSinfo. HIV treatment. FDA-approved HIV medicines. 2016. https://aidsinfo.nih.gov/education-materials/fact-sheets/21/58/fda-approved-hiv-medicines. Accessed 13 Oct 2016."},{"title3":"World Health Organization. Consolidated guidelines for the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach, 2nd edn. 2016. http://www.who.int/hiv/pub/arv/arv-2016/en/. Accessed 13 Oct 2016."},{"title3":"American Association for the Study of Liver Diseases, Infectious Diseases Society of America. HCV guidance: recommendations for testing, managing, and treating hepatitis C. 2017. http://www.hcvguidelines.org./sites/default/files/full-guidance-pdf/HCVGuidance_April_12_2017_b.pdf. Accessed 28 July 2017."},{"title3":"Treatment of hepatitis C: a systematic review"},{"title3":"Evaluation of the adverse effect of premature discontinuation of pegylated interferon alpha-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University liver disease study"},{"title3":"Therapeutics against influenza"},{"title3":"International Severe Acute Respiratory Emerging Infection Consortium. Antiviral combinations for severe influenza"},{"title3":"Advances in antivirals for non-influenza respiratory virus infections"},{"title3":"Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics"},{"title3":"Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe"},{"title3":"A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA"},{"title3":"Chimpanzee adenovirus vector Ebola vaccine"},{"title3":"A recombinant vesicular stomatitis virus Ebola vaccine"},{"title3":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial"},{"title3":"A comparative review of animal models of Middle East respiratory syndrome coronavirus infection"},{"title3":"Development of animal models against emerging coronaviruses: from SARS to MERS coronavirus"},{"title3":"Animal models of Middle East respiratory syndrome coronavirus infection"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection"},{"title3":"T cell-mediated immune response to respiratory coronaviruses"},{"title3":"Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease"},{"title3":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome"},{"title3":"Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus"},{"title3":"Severe acute respiratory syndrome-coronavirus infection in aged nonhuman primates is associated with modulated pulmonary and systemic immune responses"},{"title3":"Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species"},{"title3":"Replication of SARS coronavirus administered into the respiratory tract of African green, rhesus and cynomolgus monkeys"},{"title3":"Aerosolized Rift Valley fever virus causes fatal encephalitis in African green monkeys and common marmosets"},{"title3":"A novel highly reproducible and lethal nonhuman primate model for orthopox virus infection"},{"title3":"Susceptibility of marmosets (Callithrix jacchus) to monkeypox virus: a low dose prospective model for monkeypox and smallpox disease"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus"},{"title3":"Pharmacodynamics and systems pharmacology approaches to repurposing drugs in the wake of global health burden"},{"title3":"HIV-1 protease: mechanism and drug discovery"},{"title3":"Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1"},{"title3":"Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease"},{"title3":"Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights"},{"title3":"Development of boceprevir: a first-in-class direct antiviral treatment for chronic hepatitis C infection"},{"title3":"Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus"},{"title3":"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design"},{"title3":"Ebolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infection"},{"title3":"Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome"},{"title3":"Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids"},{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity"},{"title3":"Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus"},{"title3":"Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor library"},{"title3":"Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model"},{"title3":"Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial"},{"title3":"Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity"},{"title3":"Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins"},{"title3":"Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein"},{"title3":"Involvement of cyclophilin B in the replication of Japanese encephalitis virus"},{"title3":"Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype"},{"title3":"Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1"},{"title3":"Viral drug sensitivity testing using quantitative PCR: effect of tyrosine kinase inhibitors on polyomavirus BK replication"},{"title3":"The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patients"},{"title3":"The small molecules AZD0530 and dasatinib inhibit dengue virus RNA replication via Fyn kinase"},{"title3":"Variola and monkeypox viruses utilize conserved mechanisms of virion motility and release that depend on ABL and SRC family tyrosine kinases"},{"title3":"Inhibition of influenza A virus replication by antagonism of a PI3 K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis"},{"title3":"Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trials"},{"title3":"Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation"},{"title3":"Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, ABL and AMPK"},{"title3":"HSV activates Akt to trigger calcium release and promote viral entry: novel candidate target for treatment and suppression"},{"title3":"Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro"},{"title3":"Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes"},{"title3":"First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation"},{"title3":"Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation"},{"title3":"Sirolimus conversion may suppress viral replication in hepatitis C virus-positive renal transplant candidates"},{"title3":"The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication"},{"title3":"The multi-targeted kinase inhibitor sorafenib inhibits enterovirus 71 replication by regulating IRES-dependent translation of viral proteins"},{"title3":"Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection"},{"title3":"Myosin-actin interaction plays an important role in human immunodeficiency virus type 1 release from host cells"},{"title3":"Inhibition of SV40 DNA replication in vitro by chlorpromazine"},{"title3":"Inhibition of bovine viral diarrhea virus (BVDV) by mizoribine: synergistic effect of combination with interferon-alpha"},{"title3":"Lopinavir up-regulates expression of the antiviral protein ribonuclease L in human papillomavirus-positive cervical carcinoma cells"},{"title3":"Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle"},{"title3":"Inhibition of herpes simplex virus type 1 entry by chloride channel inhibitors tamoxifen and NPPB"},{"title3":"Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors"},{"title3":"Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the Middle East respiratory syndrome virus"},{"title3":"Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein"},{"title3":"Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease"},{"title3":"Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors"},{"title3":"Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors"},{"title3":"Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease"},{"title3":"Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro"},{"title3":"Structural basis of mercury- and zinc-conjugated complexes as SARS-CoV 3C-like protease inhibitors"},{"title3":"Investigation of the pharmacophore space of severe acute respiratory syndrome coronavirus (SARS-CoV) NTPase/helicase by dihydroxychromone derivatives"},{"title3":"2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV)"},{"title3":"Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides"},{"title3":"A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and Ebola pseudotype virus infection into human embryonic kidney 293T cells"},{"title3":"Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms"},{"title3":"Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor"}]},{"title2":"A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China."},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province."},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings."},{"title3":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds."},{"title3":"Small molecules targeting severe acute respiratory syndrome human coronavirus."},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture."},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset."},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome."},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen."},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity."},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus."},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays."},{"title3":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial."},{"title3":"International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) home page ()."},{"title3":"Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection."},{"title3":"Coronavirus disease (COVID-2019) R&amp;D. Geneva: World Health Organization ()."},{"title3":"National Early Warning Score (NEWS) 2: standardising the assessment of acute-illness severity in the NHS. London: Royal College of Physicians, 2017 ()."},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study."},{"title3":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data."},{"title3":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09."},{"title3":"Early oseltamivir after hospital admission is associated with shortened hospitalization: a 5-year analysis of oseltamivir timing and clinical outcomes."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients."},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus."}]},{"title2":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Zhou, P. et al. Nature (accepted)."}]},{"title2":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","References":[]},{"title2":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies","References":[]},{"title2":"National Health Commission of the People's Republic of China. Chinese guideline for the management COVID-19 (version 7.0, in Chinese). 2020. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf.","References":[]},{"title2":"US Food and Drug Administration. Emergency Use Authorization. Hydroxychloroquine sulfate health care provider fact sheet. https://www.fda.gov/media/136534/download.","References":[]},{"title2":"Piller C. &quot;This is insane!&quot; Many scientists lament Trump's embrace of risky malaria drugs for coronavirus. 2020. https://www.sciencemag.org/news/2020/03/insane-many-scientists-lament-trump-s-embrace-risky-malaria-drugs-coronavirus#.","References":[]},{"title2":"Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases","References":[]},{"title2":"Covid-19 - the search for effective therapy","References":[{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19"},{"title3":"We can do better : improving outcomes in the midst of an emergency."}]},{"title2":"National Health Commission of the People's Republic of China. Chinese guideline for the management covid-19 (version 5.0, in Chinese). 2020. http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a/files/ab6bec7f93e64e7f998d802991203cd6.pdf.","References":[]},{"title2":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study [correction in: BMJ 2020;368:m1295]","References":[]},{"title2":"Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study","References":[{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"World health organization. Coronavirus disease (COVID-19) outbreak situation. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 22 March 2020."},{"title3":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention"},{"title3":"Features discriminating SARS from other severe viral respiratory tract infections"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients"},{"title3":"Consistent detection of 2019 novel coronavirus in saliva"},{"title3":"National Health and Family Planning Commission of the People's Republic of China. Guideline for Diagnosis and Treatment of SARS-CoV-2 (the sixth edition). www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml. Accessed 19 February 2020."},{"title3":"Epidemiology and Relative Severity of Influenza Subtypes in Singapore in the Post-Pandemic Period from 2009 to 2010"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"He X, Lau EH, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. medRxiv 2020.20036707."},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"The aetiology, origins, and diagnosis of severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients"},{"title3":"Detection of SARS coronavirus in plasma by real-time RT-PCR"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Detection of severe acute respiratory syndrome coronavirus RNA in plasma during the course of infection"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19"},{"title3":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?"},{"title3":"The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health"},{"title3":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection"},{"title3":"Immunosenescence: Implications for response to infection and vaccination in older people"},{"title3":"Asians Do Not Exhibit Elevated Expression or Unique Genetic Polymorphisms for ACE2, the Cell-Entry Receptor of SARS-CoV-2"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"}]},{"title2":"Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America","References":[]},{"title2":"Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis","References":[]},{"title2":"Rapid onset of retinal toxicity from high-dose hydroxychloroquine given for cancer therapy","References":[]},{"title2":"An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists","References":[]},{"title2":"Oral erythromycin and the risk of sudden death from cardiac causes","References":[]},{"title2":"Antimicrobial-associated QT interval prolongation: pointes of interest","References":[]},{"title2":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","References":[]},{"title2":"Detection of SARS-CoV-2 in different types of clinical specimens","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov"},{"title3":"Smoking upregulates angiotensin-converting enzyme-2 Receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)"},{"title3":"Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Sputum and feces after conversion of pharyngeal samples in patients with COVID-19"},{"title3":"Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study"},{"title3":"Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015: elaboration and explanation"},{"title3":"An evidence-based practice guideline for the peer review of electronic search strategies"},{"title3":"PubMed, ScienceDirect, Scopus or Google Scholar:which is the best search engine for an effective literature research in laser medicine?"},{"title3":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of family cluster"},{"title3":"Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau"},{"title3":"Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously Xiong"},{"title3":"Meta-Analyst: software for meta-analysis of binary, continuous, and diagnostic data"},{"title3":"Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors"},{"title3":"Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study"}]}]}]}